Literature DB >> 2434334

2.4G2, a monoclonal antibody to macrophage Fc gamma receptors, reacts with murine T cell Fc gamma receptors and IgG-binding factors.

M Daëron, C Néauport-Sautès, U Blank, W H Fridman.   

Abstract

In order to determine whether T cell Fc gamma receptors (Fc gamma R) and IgG-binding factors (IgG-BF) are structurally related, we searched for common antigens on these molecules. We found that the anti-macrophage Fc gamma 1/gamma 2bR monoclonal antibody 2.4G2 binds to similar determinant(s) on the macrophage-like J774 cells and on the Fc gamma R+ hybridoma T cells T2D4. On the T cell membrane, these determinants are associated with Fc gamma 1/gamma 2bR. They are absent on Fc gamma R- hybridoma T cells or the FcR- BW5147 thymoma cells. 2.4G2-reactive molecules were also detected in soluble material either extracted or released in the supernatant of Fc gamma R+ hybridoma T cells. 2.4G2-reactive molecules released in the supernatant of T2D4 cells could be absorbed on Sepharose beads coupled to rabbit IgG and they were recovered by acid elution. Conversely, Sepharose beads coupled to 2.4G2 retained molecules which had affinity for rabbit IgG, which suppressed an in vitro antibody response and which had the same molecular weight as IgG-BF. These results indicate that T cell Fc gamma R and IgG-BF share common epitopes and that 2.4G2 can serve as an anti-IgG-BF antibody.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2434334     DOI: 10.1002/eji.1830161213

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF.

Authors:  C Sautès; N Mazières; A Galinha; E Tartour; C Bonnerot; S Amigorena; C Teillaud; R Spagnoli; W H Fridman
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.

Authors:  C Mathiot; S Amigorena; J Moncuit; C Sautès; W H Fridman; J L Teillaud
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

3.  Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.

Authors:  Amanda M Schell; Erica L Granger; Frank Koczot; Matthew A Fischer; Christopher C Norbury
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

4.  Release of IgD-binding factor by T cells under the influence of interleukin 2, interleukin 4, or cross-linked IgD.

Authors:  A R Amin; R F Coico; F Finkelman; G W Siskind; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  The murine c-fgr gene product associated with Ly6C and p70 integral membrane protein is expressed in cells of a monocyte/macrophage lineage.

Authors:  S Hatakeyama; K Iwabuchi; K Ogasawara; R A Good; K Onoé
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.

Authors:  E Rajnavölgyi; G Fazekas; J Lund; M Daeron; J L Teillaud; R Jefferis; W H Fridman; J Gergely
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

7.  Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice.

Authors:  A Lynch; E Tartour; J L Teillaud; B Asselain; W H Fridman; C Sautès
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

8.  Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.

Authors:  Erica L Heipertz; Michael L Davies; Eugene Lin; Christopher C Norbury
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

9.  Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction.

Authors:  F L Ierino; M S Powell; I F McKenzie; P M Hogarth
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.